Bruce D. Forrest is the President, owner and sole Investment Advisor Representative with the firm. Dr. Forrest has over 25 years of global leadership experience in pharmaceutical development with speciality expertise in, but not limited to, vaccines and biopharmaceuticals development in major and emerging markets covering biotechnology through large pharmaceutical companies.

As a Senior Vice President at Wyeth Pharmaceuticals, Dr. Forrest was responsible for all late phase development activities in Vaccines Research leading both clinical development and pharmaceutical science. He has extensive field knowledge of the pharmaceutical development environment in Asia, especially Japan, where he served as Board Member, Corporate Officer and Executive Director (Head) of R&D for Wyeth K.K. He has extensive experience in achieving global regulatory and marketing approvals for vaccines and biopharmaceuticals.

Combine this with his experience as an Investment Banker, and a reputation for innovative solutions to complex product development challenges and he is uniquely positioned to evaluate and advise on the diversity of opportunities among small, emerging growth companies in the pharmaceutical and medical device fields.

Dr. Forrest is a medical graduate (MD) from the University of Adelaide (Australia) and has an MBA from the Warwick Business School (UK).